Position in PFE
as of Jun 30, 2026
· filed Jul 9, 2026
Position Value
$6,399,380
-$827,906 QoQ
Shares Held
265,755
+3.3% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
1.87%
of 13F equity value
Holder Rank
#531
of 2,821 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 56%
Shared 0%
None 44%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026First Bank & Trust holds $30,129,113 across 10 Drug Manufacturers - General names. PFE ranks #1 (21.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | PFE |
Pfizer Inc
This page
|
265,755 | $6,399,380 | |
| 2 | ABBV |
AbbVie Inc.
|
20,753 | $5,222,284 | |
| 3 | AMGN |
Amgen Inc
|
11,014 | $3,988,389 | |
| 4 | SNY |
Sanofi
|
83,933 | $3,580,581 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
21,831 | $2,758,127 | |
| 6 | JNJ |
Johnson & Johnson
|
10,533 | $2,675,065 | |
| 7 | GSK |
GSK plc
|
41,519 | $2,176,425 | |
| 8 | MRK |
Merck & Co., Inc.
|
12,183 | $1,565,515 |
All Filings in PFE
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $6,399,380 | 265,755 | Shares | Defined | 2026-07-09 | |
| 2026-03-31 | $7,227,286 | 257,382 | Shares | Defined | 2026-04-10 | |
| 2025-12-31 | $4,585,085 | 184,140 | Shares | Defined | 2026-01-12 | |
| 2025-09-30 | $3,863,200 | 151,617 | Shares | Defined | 2025-10-10 | |
| 2025-06-30 | $1,726,275 | 71,216 | Shares | Sole | 2025-07-09 | |
| 2025-03-31 | $1,760,572 | 69,478 | Shares | Sole | 2025-04-28 | |
| 2024-12-31 | $1,761,989 | 66,415 | Shares | Sole | 2025-02-03 | |
| 2024-09-30 | $2,248,493 | 77,695 | Shares | Sole | 2024-10-24 | |
| 2024-06-30 | $2,105,103 | 75,236 | Shares | Sole | 2024-07-09 | |
| 2024-03-31 | $1,992,033 | 71,785 | Shares | Sole | 2024-04-17 | |
| 2023-12-31 | $1,221,933 | 42,443 | Shares | Sole | 2024-01-12 | |
| 2023-09-30 | $2,017,697 | 60,829 | Shares | Defined | 2023-10-11 | |
| 2023-06-30 | $2,247,823 | 61,282 | Shares | Defined | 2023-07-12 | |
| 2023-03-31 | $2,073,088 | 50,811 | Shares | Defined | 2023-04-25 | |
| 2022-12-31 | $2,130,558 | 41,580 | Shares | Defined | 2023-01-27 | |
| 2022-09-30 | $1,677,539 | 38,335 | Shares | Defined | 2022-10-28 | |
| 2022-06-30 | $1,932,831 | 36,865 | Shares | Sole | 2022-07-22 | |
| 2022-03-31 | $1,927,499 | 37,232 | Shares | Sole | 2022-04-29 | |
| 2021-12-31 | $2,266,928 | 38,390 | Shares | Sole | 2022-02-01 | |
| 2021-09-30 | $3,025,280 | 70,339 | Shares | Sole | 2021-10-18 | |
| 2021-06-30 | $2,870,584 | 73,304 | Shares | Sole | 2021-08-10 | |
| 2021-03-31 | $2,403,533 | 66,341 | Shares | Sole | 2021-04-14 | |
| 2020-12-31 | $2,260,354 | 61,406 | Shares | Sole | 2021-01-27 | |
| 2020-09-30 | $2,262,075 | 61,637 | Shares | Sole | 2020-10-26 | |
| 2020-06-30 | $1,969,980 | 60,244 | Shares | Sole | 2020-08-05 | |
| 2020-03-31 | $2,354,678 | 72,141 | Shares | Sole | 2020-04-14 | |
| No filing history on record for this holder in this stock. | ||||||